Yunnan peak through the safety standard secondary review review acceptance
Release time:
2021-01-04
Yunnan Jianfeng passed the second-level re-evaluation review and acceptance of safety standards
. From December 16 to 18, after in-depth and comprehensive on-site review by the expert group, Yunnan Jianfeng Cement Company successfully passed the on-site re-evaluation review and acceptance of safety production standardization second-level enterprises.
Yunnan Peak has been carrying out on-site inspection and rectification of safety standard re-evaluation since the beginning of the year in accordance with the requirements of the secondary standard. In order to prevent production and operation risks, all personnel attach great importance to it and set up a safety standard re-evaluation and rectification leading group, headed by General Manager Zhou Jiping, who is responsible for the establishment of safety standard.
The review expert group conducted a comprehensive review of all the contents covered by the safety standardization system through consulting basic materials, on-site inspections, employee inquiries, and examination and evaluation. According to the situation of Yunnan peak posts, the evaluation experts randomly selected 10 personnel for safety standardization related knowledge examination and evaluation. The participants included members of Yunnan peak team, middle-level cadres, supervisors, team leaders, professional and technical personnel and ordinary employees. The test results all met the requirements. After 2 days of documents, data, records, inspection and careful deliberation of on-site equipment, technology, electrical and auxiliary facilities and systems, the experts of the evaluation team agreed that the Yunnan peak safety standardization system was basically established, meeting the requirements of the second-level re-evaluation and review of the safety production standardization of cement enterprises. The on-site evaluation scored 80.0 points and agreed to pass the on-site evaluation and acceptance. Zhou Jiping, general manager of
Yunnan Jianfeng, said that Yunnan Jianfeng will actively organize rectification and reform in view of the deficiencies found in the review process. At the same time, he hoped that all departments would fully understand the seriousness of the safety management situation, further strengthen safety management and effectively prevent the occurrence of safety accidents. Taking this safety standardization review as an opportunity, we should draw inferences from one another, continuously improve and continuously improve to truly realize intrinsic safety and promote Yunnan peak safety management to a new level, achieve sustainable development, create a harmonious, happy and healthy enterprise, and ensure the realization of the safety management goal of "no accident in the enterprise and zero injury to employees. (Liu Fengbin)
More information
Publicity of Environmental Protection Acceptance for Completion of Kiln End Flue Gas Desulfurization Project of daye peak cement co., ltd. According to the requirements of the Interim Measures for Environmental Protection Acceptance for Completion of Construction Projects (No.4 [2017] of the State Environmental Regulations) issued by the Ministry of Environmental Protection, the environmental protection acceptance information of "Kiln End Flue Gas Desulfurization Project" of daye peak cement co., ltd. is now publicized. Basic Information of 1. Project Project Name: Kiln End Flue Gas Desulfurization Project Construction Unit: daye Jianfeng Cement Co., Ltd. Project Construction Location: Yongguang Village, Baoan Town, daye city, nature of the project in the existing plant area of daye Jianfeng Cement Co., Ltd.: The construction content of the technological transformation project is: This technological transformation project is mainly to build a wet desulfurization system for kiln end gas of the company's existing 4000t cement clinker production line, adopting limestone-gypsum wet flue gas desulfurization process. The project covers a total area of 500 m2, with a new construction area of about 450 m2. It mainly builds desulfurization complex building, flue gas system, SO2 absorption system, limestone powder conveying and limestone slurry preparation system, process water system, gypsum dehydration system and supporting pipelines. Power supply, water supply, compressed air and other public works rely on the existing plant. Total investment and environmental protection investment: the total investment of the project is 10.37 million yuan, all of which are environmental protection investment. The project was entrusted to Huangshi Yangtze River Environmental Engineering Design and Research Institute to carry out environmental impact assessment in September 2017. On November 16, 2017, Daye Municipal Environmental Protection Bureau issued a reply with YEHAN [2017] No. 354. Implementation of 2. environmental protection measures The scope of this acceptance is the flue gas desulfurization system and supporting facilities at the end of the kiln. (1) Exhaust gas pollution
2020
07-31
Spike New Drug Approved for Registration
On April 16, Jianfeng Pharmaceutical Company received the approval and issuance of Olopatadine Hydrochloride Eye Drops "Drug Registration Approval" (approval number: 2019S00296) approved by the State Drug Administration. Olopatadine hydrochloride eye drops is mainly used to treat the signs and symptoms of allergic conjunctivitis. It is a mast cell stabilizer and a relatively selective histamine H1-receptor antagonist. It can inhibit type I immediate allergic reactions in vivo and in vitro experiments. At present, the product has been included in the "National Basic Medical Insurance, Work Injury Insurance and Maternity Insurance Drug Catalog (2017 Edition)" and classified as Class B. According to the relevant data of IMS database, in 2018, the global sales of olopatadine hydrochloride eye drops were about 0.37 billion US dollars, and the sales in China were about 10.232 million US dollars. Spike Pharmaceuticals already has the corresponding production line, this time to obtain the registration approval, marking Spike Pharmaceuticals has the qualification to carry out the production and sales of olopatadine hydrochloride eye drops, will further enrich the product line of Spike Pharmaceuticals, help to enhance the competitiveness of the company's pharmaceutical business. (Xia Yingpin)
2020
07-31
Spike New Drug Approved for Registration
On April 16, Jianfeng Pharmaceutical Company received the approval and issuance of Olopatadine Hydrochloride Eye Drops "Drug Registration Approval" (approval number: 2019S00296) approved by the State Drug Administration. Olopatadine hydrochloride eye drops is mainly used to treat the signs and symptoms of allergic conjunctivitis. It is a mast cell stabilizer and a relatively selective histamine H1-receptor antagonist. It can inhibit type I immediate allergic reactions in vivo and in vitro experiments. At present, the product has been included in the "National Basic Medical Insurance, Work Injury Insurance and Maternity Insurance Drug Catalog (2017 Edition)" and classified as Class B. According to the relevant data of IMS database, in 2018, the global sales of olopatadine hydrochloride eye drops were about 0.37 billion US dollars, and the sales in China were about 10.232 million US dollars. Spike Pharmaceuticals already has the corresponding production line, this time to obtain the registration approval, marking Spike Pharmaceuticals has the qualification to carry out the production and sales of olopatadine hydrochloride eye drops, will further enrich the product line of Spike Pharmaceuticals, help to enhance the competitiveness of the company's pharmaceutical business. (Xia Yingpin)
2020
07-31
Contact Us
No. 88 Wujiang East Road, Jinhua City, Zhejiang Province, China
Tel: +86-579-82326868
Fax : +86-579-82324666
©2023 Zhejiang Jianfeng Group Co., Ltd. Powered by: www.300.cn SEO Business License
SAF Coolest v1.2 设置面板 SHJSS-AHDB-FSSQE-ZSW
无数据提示
Sorry, the current column has no content !
You can view other columns or return to Home Page